These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38653088)

  • 1. Dendritic cell-derived exosome (DEX) therapy for digestive system cancers: Recent advances and future prospect.
    Al-Hawary SIS; Almajidi YQ; Bansal P; Ahmad I; Kaur H; Hjazi A; Deorari M; Zwamel AH; Hamzah HF; Mohammed BA
    Pathol Res Pract; 2024 May; 257():155288. PubMed ID: 38653088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models.
    Lu Z; Zuo B; Jing R; Gao X; Rao Q; Liu Z; Qi H; Guo H; Yin H
    J Hepatol; 2017 Oct; 67(4):739-748. PubMed ID: 28549917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic Cell-Derived Exosomes in Cancer Immunotherapy.
    Luo S; Chen J; Xu F; Chen H; Li Y; Li W
    Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes from Dendritic Cells Loaded with Chaperone-Rich Cell Lysates Elicit a Potent T Cell Immune Response Against Intracranial Glioma in Mice.
    Bu N; Wu H; Zhang G; Zhan S; Zhang R; Sun H; Du Y; Yao L; Wang H
    J Mol Neurosci; 2015 Jul; 56(3):631-43. PubMed ID: 25680514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmacytoid Dendritic Cells and Cancer Immunotherapy.
    Fu C; Zhou L; Mi QS; Jiang A
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress of dendritic cell-derived exosomes (Dex) as an anti-cancer nanovaccine.
    Xia J; Miao Y; Wang X; Huang X; Dai J
    Biomed Pharmacother; 2022 Aug; 152():113250. PubMed ID: 35700679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
    Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
    Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Cell-associated Exosomes Robustly Elicit Anti-tumor Immune Responses through Modulating Dendritic Cell Vaccines in Lung Tumor.
    Wang C; Huang X; Wu Y; Wang J; Li F; Guo G
    Int J Biol Sci; 2020; 16(4):633-643. PubMed ID: 32025211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
    Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
    Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexosomes as a cell-free vaccine for cancer immunotherapy.
    Nikfarjam S; Rezaie J; Kashanchi F; Jafari R
    J Exp Clin Cancer Res; 2020 Nov; 39(1):258. PubMed ID: 33228747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DC-Based Vaccines for Cancer Immunotherapy.
    Fu C; Zhou L; Mi QS; Jiang A
    Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33255895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunogenicity of dendritic cell-derived exosomes.
    Quah BJ; O'Neill HC
    Blood Cells Mol Dis; 2005; 35(2):94-110. PubMed ID: 15975838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice.
    Wang L; Xie Y; Ahmed KA; Ahmed S; Sami A; Chibbar R; Xu Q; Kane SE; Hao S; Mulligan SJ; Xiang J
    Breast Cancer Res Treat; 2013 Jul; 140(2):273-84. PubMed ID: 23881522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides.
    Hsu DH; Paz P; Villaflor G; Rivas A; Mehta-Damani A; Angevin E; Zitvogel L; Le Pecq JB
    J Immunother; 2003; 26(5):440-50. PubMed ID: 12973033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell-derived exosomes as immunotherapies in the fight against cancer.
    Pitt JM; Charrier M; Viaud S; André F; Besse B; Chaput N; Zitvogel L
    J Immunol; 2014 Aug; 193(3):1006-11. PubMed ID: 25049431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
    Hao S; Yuan J; Xiang J
    J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR-3 stimulation improves anti-tumor immunity elicited by dendritic cell exosome-based vaccines in a murine model of melanoma.
    Damo M; Wilson DS; Simeoni E; Hubbell JA
    Sci Rep; 2015 Dec; 5():17622. PubMed ID: 26631690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell-derived exosomes for cancer therapy.
    Pitt JM; André F; Amigorena S; Soria JC; Eggermont A; Kroemer G; Zitvogel L
    J Clin Invest; 2016 Apr; 126(4):1224-32. PubMed ID: 27035813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell biology and its role in tumor immunotherapy.
    Wang Y; Xiang Y; Xin VW; Wang XW; Peng XC; Liu XQ; Wang D; Li N; Cheng JT; Lyv YN; Cui SZ; Ma Z; Zhang Q; Xin HW
    J Hematol Oncol; 2020 Aug; 13(1):107. PubMed ID: 32746880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes.
    Hao S; Bai O; Yuan J; Qureshi M; Xiang J
    Cell Mol Immunol; 2006 Jun; 3(3):205-11. PubMed ID: 16893501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.